RAND
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Low P/B suggests value, but high PEG indicates the price is too high for the current growth trajectory.
- P/B ratio of 0.61
- High PEG ratio of 3.13
- P/S ratio of 4.95
Severe revenue contraction suggests a shrinking business model.
- Revenue growth -39.90%
- Negative ROE
Recent performance is sharply negative, erasing long-term gains.
- 3Y Change +35.3%
- 1Y Change -39.0%
- 6M Change -14.3%
Liquidity is high, but operational health is failing.
- High Current Ratio (7.53)
- Piotroski F-Score 2/9
- Negative Profit Margin
Yield is attractive but sustainability is highly questionable given the -124% profit margin.
- High yield 10.74%
- Moderate payout ratio 51.48%
- Lack of earnings to support dividends
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for RAND and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
RAND
Rand Capital Corporation
Primary
|
+0.3% | +35.3% | -39.0% | -14.3% | +0.2% | -3.5% |
|
GRAN
Grande Group Limited
Peer
|
-72.4% | -72.4% | -72.4% | -57.7% | -24.4% | +13.4% |
|
BNKK
Bonk, Inc.
Peer
|
-96.9% | -72.4% | -65.3% | -76.8% | +83.6% | +72.7% |
|
HERZ
Herzfeld Credit Income Fund, Inc.
Peer
|
-1.1% | +15.1% | +35.1% | +21.4% | -6.3% | +2.7% |
|
GOCO
GoHealth, Inc.
Peer
|
-99.4% | -92.5% | -89.7% | -76.4% | -49.3% | -17.6% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Financial Services Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
RAND
Rand Capital Corporation
|
BEARISH | $32.07M | - | -13.7% | -124.2% | $10.8 | |
|
GRAN
Grande Group Limited
|
BEARISH | $31.63M | - | -5.8% | -9.8% | $1.27 | Compare |
|
BNKK
Bonk, Inc.
|
BEARISH | $32.68M | - | -93.7% | -% | $6.06 | Compare |
|
HERZ
Herzfeld Credit Income Fund, Inc.
|
BEARISH | $31.41M | 80.6 | -3.2% | -80.7% | $16.12 | Compare |
|
GOCO
GoHealth, Inc.
|
BEARISH | $30.29M | - | -219.7% | -71.1% | $1.05 | Compare |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
RAND has transitioned to an investment strategy focused on higher-yielding debt and elected status as a regulated investment company (RIC). Financial highlights include quarterly dividends of $0.29 per share for the first nine months of 2025 and a special dividend of $4.20 per share paid in January 2025, consisting of 20% cash and 80% stock. The company remains subject to Business Development Company regulations.
RAND has transitioned to an investment strategy focused on higher-yielding debt and elected U.S. Federal tax treatment as a regulated investment company (RIC). Financial highlights include quarterly cash dividends of $0.29 per share for the first half of 2025 and a $4.20 per share dividend paid in January 2025, consisting of 20% cash and 80% stock. Specific risk factors were not detailed in the provided excerpts.
Past News Coverage
Recent headlines mentioning RAND from our newsroom.